Abstract
534 Filaggrin mutations are common in a US group of white patients with severe atopic dermatitis (48.5%). Filaggrin mutation analysis in patients with severe atopic dermatitis may be useful for the clinician because it provides a genetic basis to the severity of the disease process and predicts the atopic march as a loss of function mutations confer genetic risks to the development of peanut allergy, allergic rhinitis, and asthma in the presence of eczema. New therapies are being developed to augment filaggrin expression in atopic dermatitis skin and patients will filaggrin mutations may benefit the most from this information. 3702delG/WT 0.0 (0.0)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Allergy and Clinical Immunology: In Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
